2023 Pharma Predictions

Ravi Samavedam
2023 Pharma Predictions Teaser

In this Pharma Manufacturing article, you will gain insight into industry predictions of life science leaders for 2023.

“Bridge facilities are becoming a cost-effective way for pharma manufacturers to scale their operations to meet demand without building facilities that may remain largely vacant.” 
- Ravi Samavedam, Chief Innovation Officer at Azzur Group

Read the full article published on Pharma Manufacturing's website and featured in their January/February magazine issue or learn more about the unique hybrid model, Azzur Cleanrooms on Demand™, that is accommodating the growing demand in the biomanufacturing market. 


Ravi Samavedam Headshot

Ravi Samavedam

Ravi Samavedam joined Azzur Group in 2012 and is a Biochemical Engineer with more than 20 years of experience. Prior to his appointment to Chief Innovation Officer (CINO), Ravi served as President of Azzur Cleanrooms on Demand™ and previously was a General Manager of Azzur Boston. Ravi has been a part of technical operations, quality, and validation departments at some of the world’s foremost pharmaceutical manufacturers. He is an expert in phase-appropriate cGMP implementation, process validation, supplier management, and technology transfer. Ravi is an active member of industry and peer groups, and he is a frequent speaker at industry events.
Connect On Linkedin